2018
DOI: 10.1016/j.pdpdt.2018.06.027
|View full text |Cite
|
Sign up to set email alerts
|

Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer

Abstract: Hypericin-PDT has reduced efficacy in CRC spheroids as compared to 2D cultures, which may be attributable through upregulation in ABCG2. The clinical efficacy of Hypericin-PDT may be enhanced by ABCG2 inhibition.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(25 citation statements)
references
References 42 publications
0
23
0
1
Order By: Relevance
“…For our experiments, the human colorectal adenocarcinoma cell line, HT29, was used to generate 3D spheroids. HT29 has been used extensively in 3D cell culturing based studies, and from previous multiple studies, we have found HT29 to form spheroidal cultures with relative ease [45][46][47][48] . As demonstrated in Figs.…”
Section: Discussionmentioning
confidence: 81%
“…For our experiments, the human colorectal adenocarcinoma cell line, HT29, was used to generate 3D spheroids. HT29 has been used extensively in 3D cell culturing based studies, and from previous multiple studies, we have found HT29 to form spheroidal cultures with relative ease [45][46][47][48] . As demonstrated in Figs.…”
Section: Discussionmentioning
confidence: 81%
“…43,73,74 Studies by Mikešová et al (2013) noted that the combination of glutathione level and NAD(P)H/FAD redox status when combined with hypericin in CRC cancer cells affects its resistance to PDT. 89 Moreover, studies by Khot et al (2018), treated spheroidal CRC cell models with hypericin PDT and noted signicant resistance, with high expression levels of ABCG2 and suggested that possibly by inhibiting ABCG2 expression that this could potentially enhance the efficacy of hypericin-mediated PDT. 90 Additionally, studies by Halaburková et al (2017), reported enhanced CRC hypericin mediated PDT within in vitro cultured HT-29 cells using histone deacetylase inhibitors (HDACis) to sensitize CRC cells external stimuli to overcoming their resistance to hypericin by epigenetically reactivating the expression of CDKN1A.…”
Section: Photosensitizers For Pdd and Pdt Colorectal Cancer Applicationsmentioning
confidence: 99%
“…89 Moreover, studies by Khot et al (2018), treated spheroidal CRC cell models with hypericin PDT and noted signicant resistance, with high expression levels of ABCG2 and suggested that possibly by inhibiting ABCG2 expression that this could potentially enhance the efficacy of hypericin-mediated PDT. 90 Additionally, studies by Halaburková et al (2017), reported enhanced CRC hypericin mediated PDT within in vitro cultured HT-29 cells using histone deacetylase inhibitors (HDACis) to sensitize CRC cells external stimuli to overcoming their resistance to hypericin by epigenetically reactivating the expression of CDKN1A. 91 Studies by Montanha et al (2017) improved the water solubility of hypericin and its PDT effect within in vitro cultured Caco-2 and HT-29 CRC cells by encapsulating it in Pluronic P123 (P123).…”
Section: Photosensitizers For Pdd and Pdt Colorectal Cancer Applicationsmentioning
confidence: 99%
“…Previous studies have shown a selective accumulation of ALA-induced PpIX in oral potentially malignant disorders and malignant tissues, which is probably due to (1) limited capacity and/or low activity of ferrochelatase [ 15 ]; (2) differential PDT sensitivity in various cancer cell lines in combination with ABCG2 inhibition [ 16 ]. As ABCG2 has previously been shown to be critical for ALA-PDT in different human cancers, including brain and colorectal cancers [ 17 , 18 , 19 ], inhibition of ABCG2 could potentially enhance the efficacy of ALA-PDT in treatment of HNC.…”
Section: Introductionmentioning
confidence: 99%